A, M., J, B., & A, Z. H. (2023). Metagenome analyses identify human endogenous retrovirus-K113 (HML-2) subtype in glioblastoma. The Journal of clinical investigation, 133(24), . https://doi.org/10.1172/JCI173959
Chicago Style (17th ed.) CitationA, Macamo, Beckervordersandforth J, and Zur Hausen A. "Metagenome Analyses Identify Human Endogenous Retrovirus-K113 (HML-2) Subtype in Glioblastoma." The Journal of Clinical Investigation 133, no. 24 (2023). https://doi.org/10.1172/JCI173959.
MLA (9th ed.) CitationA, Macamo, et al. "Metagenome Analyses Identify Human Endogenous Retrovirus-K113 (HML-2) Subtype in Glioblastoma." The Journal of Clinical Investigation, vol. 133, no. 24, 2023, https://doi.org/10.1172/JCI173959.
Warning: These citations may not always be 100% accurate.